Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Hoyeraal-Hreidarsson syndrome (HHS) is a severe autosomal recessive telomere biology disorder characterized by intrauterine growth retardation, microcephaly and cerebellar hypoplasia, along with mucocutaneous features of dyskeratosis congenita. Biallelic loss-of-function variants in the telomerase reverse transcriptase gene TERT underlie AR-HHS through critically short telomeres and impaired telomerase activity.
Multiple consanguineous and non-consanguineous families have been reported with homozygous or compound heterozygous TERT variants segregating with full-blown short telomere syndrome phenotypes. In one cohort, two unrelated probands with classical dyskeratosis congenita or HHS harbored homozygous missense variants c.2431C>T (p.Arg811Cys) and c.2701C>T (p.Arg901Trp) leading to nearly absent telomerase activity and extremely short telomeres (PMID:17785587). A separate report described two siblings with HHS due to a homozygous c.1700C>T (p.Thr567Met) TERT mutation that markedly impaired telomerase processivity (PMID:23538340). More recently, an index case from a consanguineous Turkish family was shown to carry c.2011C>T (p.Arg671Trp), with segregation of this variant in the affected child and short telomere lengths in carriers (PMID:34890115).
Overall, at least five independent probands across three families exhibit AR inheritance with segregation of TERT variants in affected relatives, confirming the gene-disease link (PMID:17785587, PMID:23538340, PMID:34890115). The variant spectrum includes missense substitutions in the reverse transcriptase and T-motif domains, with no recurrent founder alleles reported to date.
Functional studies consistently demonstrate that patient-derived cells or in vitro reconstitution of TERT mutants have dramatically reduced telomerase enzymatic activity, processivity defects, and critically short telomeres, establishing a loss-of-function mechanism of haploinsufficiency for telomere maintenance.
No significant conflicting evidence has been reported. Heterozygous carriers may develop adult-onset telomere syndromes such as pulmonary fibrosis or bone marrow failure, underscoring dose sensitivity of TERT activity.
In summary, genetic and experimental data support a strong association between biallelic TERT variants and AR HHS. Genetic testing for TERT mutations and telomere length measurement are essential for diagnosis and family counseling.
Gene–Disease AssociationStrongBiallelic/homozygous TERT pathogenic variants in five independent probands from three families, autosomal recessive inheritance, segregation and concordant telomerase functional data Genetic EvidenceStrongAutosomal recessive inheritance with segregation in siblings; five probands with homozygous or compound heterozygous TERT variants Functional EvidenceModerateMultiple studies demonstrate reduced telomerase activity and critically short telomeres in patient cells and in vitro assays |